Why is awareness not enough in rare diseases? See the gap between visibility and understanding, and its impact on diagnosis, care, and research.
Why Awareness Does Not Always Mean Understanding
Why is awareness not enough in rare diseases? See the gap between visibility and understanding, and its impact on diagnosis, care, and research.
What a New Gene Discovery Actually Means
Gene discoveries are often misunderstood. Learn what a new gene finding really means for diagnosis, research, and patient care in rare diseases.
Common Misconceptions About Rare Diseases
Rare diseases affect millions worldwide. Let's explore common misconceptions about genetics, treatment access, research, and public health.
Orphan Drugs: From Neglect to Precision Medicine
Although orphan drug legislation and genomic science have transformed the therapeutic landscape for rare diseases, the path from scientific discovery to patient access remains complex and uncertain.
Understanding Inheritance Patterns in Genetic Conditions
A clear guide to genetic inheritance patterns, explaining how conditions are passed through families and why outcomes can vary across generations.
Support For Rare Disease Patients and Families
Rare disease support: NORD, Global Genes, peer groups, financial help, insurance guidance, and online communities to fight isolation.
The Financial Burden of Rare Diseases on Families
Rare diseases create hidden financial strain through delayed diagnosis, costly treatments, income loss, and long-term care burdens.
Telehealth for Rare Diseases: How Remote Care Makes a Difference
Telehealth is transforming rare disease care by improving access to specialists, supporting remote monitoring, and reducing barriers to care.
FDA's New Breakthrough Pathways for Rare Disease Treatments
A clear overview of the FDA’s new 2025 pathways transforming rare disease drug development, including RDEP, guidance updates, and mechanism based approval.
Understanding Rare Diseases: An Overview of Definitions and Prevalence
Discover how rare diseases are defined worldwide, why definitions differ, and what current data reveals about prevalence, diagnosis delays, and the treatment gap.